These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3336207)

  • 21. Prevention of vascular prosthetic infection with an antibiotic-bonded Dacron graft.
    Shue WB; Worosilo SC; Donetz AP; Trooskin SZ; Harvey RA; Greco RS
    J Vasc Surg; 1988 Nov; 8(5):600-5. PubMed ID: 2972845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle flaps in the management of vascular grafts in contaminated wounds: an experimental study in dogs.
    Cruz NI; Canario QM
    Plast Reconstr Surg; 1988 Sep; 82(3):480-5. PubMed ID: 3406182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental and clinical studies on prevention of vascular prosthetic infection].
    Kurata H
    Nihon Geka Gakkai Zasshi; 1989 Aug; 90(8):1251-7. PubMed ID: 2811844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of muscle flaps in the treatment of prosthetic vascular graft infections.
    Dacey LJ; Miett TO; Huntsman WT; Colen LB; Schned AR; McDaniel MD
    J Surg Res; 1988 May; 44(5):566-72. PubMed ID: 3374120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Light and electron microscopic studies of an antibiotic bonded vascular graft.
    Greco RS; Tesoriero JV; Smilow PC; Harvey RA
    J Cardiovasc Surg (Torino); 1984; 25(6):489-97. PubMed ID: 6511811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Which antibiotics should one choose for prophylaxis in vascular surgery?].
    Veit R; Melliere D; Etienne G; Becquemin JP; Brunbuisson C; Otterbein G
    J Chir (Paris); 1986 Nov; 123(11):621-5. PubMed ID: 3611218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin glue-antibiotic suspension in the prevention of prosthetic graft infection.
    Ney AL; Kelly PH; Tsukayama DT; Bubrick MP
    J Trauma; 1990 Aug; 30(8):1000-5; discussion 1005-6. PubMed ID: 2201786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
    Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
    Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amikacin-loaded vascular prosthesis as an effective drug carrier.
    Ginalska G; Kowalczuk D; Osińska M
    Int J Pharm; 2007 Jul; 339(1-2):39-46. PubMed ID: 17376617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic bonding to vascular prostheses.
    Henry R; Harvey RA; Greco RS
    J Thorac Cardiovasc Surg; 1981 Aug; 82(2):272-7. PubMed ID: 7253690
    [No Abstract]   [Full Text] [Related]  

  • 31. Simple methods for direct antibiotic protection of synthetic vascular grafts.
    White JV; Benvenisty AI; Reemtsma K; Voorhees AB; Fox CL; Modak S; Nowygrod R
    J Vasc Surg; 1984 Mar; 1(2):372-80. PubMed ID: 6237210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifampicin-soaked silver polyester versus expanded polytetrafluoro-ethylene grafts for in situ replacement of infected grafts in a porcine randomised controlled trial.
    Gao H; Sandermann J; Prag J; Lund L; Lindholt JS
    Eur J Vasc Endovasc Surg; 2012 May; 43(5):582-7. PubMed ID: 22421376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of anti-bacterial prophylactic properties of two different vascular grafts: action of anti-bacterial graft coating and systemic antibiotic treatment.
    Artini M; Scoarughi GL; Papa R; Cellini A; Avanzolini C; Mileto E; Rizzo L; Selan L
    Int J Immunopathol Pharmacol; 2010; 23(1):383-6. PubMed ID: 20394708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics.
    Javerliat I; Goëau-Brissonnière O; Sivadon-Tardy V; Coggia M; Gaillard JL
    J Vasc Surg; 2007 Nov; 46(5):1026-31. PubMed ID: 17905555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an infection-resistant vascular prosthesis.
    Moore WS; Chvapil M; Seiffert G; Keown K
    Arch Surg; 1981 Nov; 116(11):1403-7. PubMed ID: 6458258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of bacterial adhesion by antibacterial surface pretreatment of vascular prostheses.
    Webb LX; Myers RT; Cordell AR; Hobgood CD; Costerton JW; Gristina AG
    J Vasc Surg; 1986 Jul; 4(1):16-21. PubMed ID: 3723687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
    Yasim A; Gul M; Ciralik H; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of early vascular graft infection using regional antibiotic release.
    Kuehn C; Graf K; Mashaqi B; Pichlmaier M; Heuer W; Hilfiker A; Stiesch M; Chaberny IF; Haverich A
    J Surg Res; 2010 Nov; 164(1):e185-91. PubMed ID: 20828762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prosthetic Graft Patency in the Setting of a Polymicrobial Infection in Swine (Sus scrofa).
    Stull MC; Clemens MS; Heafner TA; Watson JDB; Arthurs ZM; Propper BW
    Ann Vasc Surg; 2016 Oct; 36():265-272. PubMed ID: 27423719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of biodegradable amikacin microspheres to prevent vascular graft infection.
    Ney AL; Granja JA; Schuster PA; Tsukayama DT; Jacobs DM; Bubrick MP
    J Surg Res; 1994 Dec; 57(6):698-705. PubMed ID: 7996849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.